SPECIAL CONSIDERATION OF ANTIBACTERIAL THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
https://doi.org/10.18093/0869-0189-2016-26-5-618-622
Abstract
Current guidelines consider timely diagnosis, treatment and prevention of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) as an important goal of the management of patients with COPD. Frequent AECOPD accelerate lung function declining and decrease quality of life. AECOPD are essentially associated with worsening of the mucociliary clearance and are caused unfrequently by respiratory infection. A case report is included in the article. A male with AECOPD was treated with inhalation therapy without systemic antibiotics. Thiamphenicol, glycinate acetylcysteinate (Fluimucil antibiotic IT) was used along with the standard therapy of AECOPD due to its antibacterial, antioxidant and mucolytic activity. Dyspnea, sputum expectoration, physical tolerance of the patient and rhonchi on auscultation improved in 3 days of treatment. The authors have concluded that administration of this drug allowed reduction drug load and decrease a risk of adverse events associated with systemic drug exposure.
About the Authors
I. V. DemkoRussian Federation
MD, Professor, Head of Department of Internal Medicine No.2 and Postgraduate Physician Training Course, V.F.Voyno-Yasenetskiy Krasnoyarsk State Medical University, Healthcare Ministry of Russia
E. A. Sobko
Russian Federation
MD, Associate Professor at Head of Department of Internal Medicine No.2 and Postgraduate Physician Training Course, V.F.Voyno-Yasenetskiy Krasnoyarsk State Medical University, Healthcare Ministry of Russia; Head of Division of Pulmonology and Allergy, Krasnoyarsk State Territorial Clinical Hospital
I. A. Solov'eva
Russian Federation
PhD, Assistant Lecturer, Department of Internal Medicine No.2 and Postgraduate Physician Training Course, V.F.Voyno-Yasenetskiy Krasnoyarsk State Medical University, Healthcare Ministry of Russia
O. P. Ishchenko
Russian Federation
PhD, Assistant Lecturer at Department of Internal Medicine No.2 and Postgraduate Physician Training Course, V.F.Voyno-Yasenetskiy Krasnoyarsk State Medical University, Healthcare Ministry of Russia; allergist at Krasnoyarsk State Territorial Clinical Hospital
A. Yu. Kraposhina
Russian Federation
PhD, Assistant Lecturer at Department of Internal Medicine No.2 and Postgraduate Physician Training Course, V.F.Voyno-Yasenetskiy Krasnoyarsk State Medical University, Healthcare Ministry of Russia
N. V. Gordeeva
Russian Federation
PhD, Senior Researcher, Department of Internal Medicine No.2 and Postgraduate Physician Training Course, V.F.Voyno-Yasenetskiy Krasnoyarsk State Medical University, Healthcare Ministry of Russia
S. V. Chubarova
Russian Federation
PhD, Assistant Lecturer at Department of Internal Medicine No.2 and Postgraduate Physician Training Course, V.F.Voyno-Yasenetskiy Krasnoyarsk State Medical University, Healthcare Ministry of Russia; allergist at Krasnoyarsk State Territorial Clinical Hospital
M. G. Mamaeva
Russian Federation
PhD, pulmonologist at Krasnoyarsk State Territorial Clinical Hospital
References
1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2013. Available at www.goldcopd.org.
2. Hurst J.R., Vestbo J., Anzueto A. et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 2010; 363: 1128–1138.
3. Anthonisen N.R., Manfreda J., Warren C.P. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106: 196–204.
4. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2015. Available at: www.goldcopd.org
5. Donaldson G.C., Seemungal T.A., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002; 57: 847–852.
6. Soler-Cataluna J.J., Martinez-Garcia M.A., Sanchez R.P. et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005; 60: 925–931.
7. Pavord I.D., Jones P.W., Burgel P.R., Rabe K.F. Exacerbations of COPD. Int. J. Chron. Obstruct. Pulm. Dis. 2016; 11 (Spec. Iss.): 21–30.
8. Sinopal'nikov A.I., Zaytsev A.A. Current view on pharmacotherapy of acute exacerbations of chronic obstructive pulmonary disease. Lechashchiy vrach. 2009; 10 (in Russian).
9. Dy R., Sethi S. The lung microbiome and exacerbations of COPD. Curr. Opin. Pulm. Med. 2016; 22 (3): 196–202.
10. Sinopal'nikov A.I., Romanovskikh A.G. Infectious exacerbation of chronic obstructive pulmonary disease. In: Sinopal'nikov A.I., Kozlov R.S. Community-Acquired Respiratory Infections. A Handbook for Physicians. Moscow: Prem'er MT, Nash Gorod; 2007 (in Russian).
11. Miravitlles M., Murio C., Guerrero T., Gisbert R. Cost of chronic bronchitis and COPD: a 1-year follow-up study. Chest. 2003; 123: 784–791.
12. Hurst J.R., Wedzicha J.A. Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review. BMC Med. 2009; 7: 40–45.
13. Uteshev D.B., Bunyatyan N.D., Karabinenko A.A., Krylov I.A. Bronchial kinetics and mucociliary clearance disorders in COPD. Russkiy meditsinskiy zhurnal 2010; 9: 530 (in Russian).
14. Khodzitskaya V.K., Khodzitskaya S.V. Mucociliary clearance disorders and their improvement in respiratory diseases. Bolezni i antibiotiki. 2010; 1 (3) (in Russian).
15. Chikina S.Yu., Belevskiy A.S. Mucociliary clearance in health and in diseases. Prakticheskaya pul'monologiya. 2012; 1 (44): 2–5 (in Russian).
16. Poole P.J., Black P.N. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. Br. Med. J. 2001; 322: 1271–1274.
17. Stey C., Steurer J., Bachmann S. et al. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur. Respir. J. 2000; 16: 253–262.
18. Sinopal'nikov A.I., Klyachkina I.L. A role of inhaled mucolytics in therapy of acute exacerbations of chronic obstructive pulmonary disease. Atmosfera. Pul'monologiya i allergologiya. 2002; 3 (in Russian).
19. Chuchalin A.G., Aysanov Z.R., Avdeev S.N., et al. Federal Clinical Guidelines on Diagnosis and Management of Chronic Obstructive Pulmonary Disease. Moscow: RRO; 2014 (in Russian).
Review
For citations:
Demko I.V., Sobko E.A., Solov'eva I.A., Ishchenko O.P., Kraposhina A.Yu., Gordeeva N.V., Chubarova S.V., Mamaeva M.G. SPECIAL CONSIDERATION OF ANTIBACTERIAL THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. PULMONOLOGIYA. 2016;26(5):618-622. (In Russ.) https://doi.org/10.18093/0869-0189-2016-26-5-618-622